EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Development of Potential Therapeutic Agents from Black Elderberries (the Fruits of Sambucus nigra L.)

Yulin Ren iD, Gunnar Meyer, Andrew T Anderson iD, Kaitlyn M Lauber, Judith C Gallucci, Gary Gao iD, Alan Douglas Kinghorn iD

Molecules · 2024

DOI: 10.3390/molecules29132971 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2024. Verfasst von Yulin Ren und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. Hauptthemen laut MEDLINE: Sambucus nigra, Fruit, Plant Extracts. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elderberry (Sambucus nigra L.) is a widespread deciduous shrub, of which the fruits (elderberries) are used in the food industry to produce different types of dietary supplement products. These berries have been found to show multiple bioactivities, including antidiabetic, anti-infective, antineoplastic, anti-obesity, and antioxidant activities. An elderberry extract product, Sambucol®, has also been used clinically for the treatment of viral respiratory infections. As the major components, phenolic compounds, such as simple phenolic acids, anthocyanins and other flavonoids, and tannins, show promising pharmacological effects that could account for the bioactivities observed for elderberries. Based on these components, salicylic acid and its acetate derivative, aspirin, have long been used for the treatment of different disorders. Dapagliflozin, an FDA-approved antidiabetic drug, has been developed based on the conclusions obtained from a structure–activity relationship study for a simple hydrolyzable tannin, β-pentagalloylglucoside (β-PGG). Thus, the present review focuses on the development of therapeutic agents from elderberries and their small-molecule secondary metabolites. It is hoped that this contribution will support future investigations on elderberries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sambucus nigraFruitPlant ExtractsHumansAntioxidantsHypoglycemic AgentsAnimalsAnti-Infective Agents

Stichwörter der Autor:innen

Sambucol®antioxidantsantitumorantiviralelderberriesphenolic constituentstherapeutic agents

Substanzen

Plant ExtractsAntioxidantsHypoglycemic AgentsAnti-Infective Agents

Autor:innen und Institutionen

  • Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
  • OSU South Centers, The Ohio State University, Piketon, OH 45661, USA.
  • Department of Horticulture and Crop Science, College of Food, Agricultural, and Environmental Sciences, The Ohio State University, Columbus, OH 43210, USA.

ORCID-Profile: Yulin Ren, Andrew T Anderson, Gary Gao, Alan Douglas Kinghorn

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Cancer Institute, National Institutes of Health

Zitieren

APA

Ren, Y., Meyer, G., Anderson, A. T., Lauber, K. M., Gallucci, J. C., Gao, G., & Kinghorn, A. D. (2024). Development of Potential Therapeutic Agents from Black Elderberries (the Fruits of Sambucus nigra L.). Molecules. https://doi.org/10.3390/molecules29132971

Vancouver

Ren Y, Meyer G, Anderson AT, Lauber KM, Gallucci JC, Gao G, et al. Development of Potential Therapeutic Agents from Black Elderberries (the Fruits of Sambucus nigra L.). Molecules. 2024. doi:10.3390/molecules29132971

BibTeX
@article{Ren2024,
  author = {Ren, Yulin and Meyer, Gunnar and Anderson, Andrew T and Lauber, Kaitlyn M and Gallucci, Judith C and Gao, Gary and Kinghorn, Alan Douglas},
  title = {Development of Potential Therapeutic Agents from Black Elderberries (the Fruits of Sambucus nigra L.)},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29132971}
}
Kostenlos starten →